SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-16-016692
Filing Date
2016-11-14
Accepted
2016-11-14 17:37:19
Documents
64
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2230223z10-q.htm 10-Q 477823
2 EX-31.1 a2230223zex-31_1.htm EX-31.1 7471
3 EX-31.2 a2230223zex-31_2.htm EX-31.2 7612
4 EX-32.1 a2230223zex-32_1.htm EX-32.1 4525
5 EX-32.2 a2230223zex-32_2.htm EX-32.2 4505
  Complete submission text file 0001047469-16-016692.txt   4355728

Data Files

Seq Description Document Type Size
6 EX-101.INS ctrv-20160930.xml EX-101.INS 942917
7 EX-101.SCH ctrv-20160930.xsd EX-101.SCH 53325
8 EX-101.CAL ctrv-20160930_cal.xml EX-101.CAL 36200
9 EX-101.DEF ctrv-20160930_def.xml EX-101.DEF 224719
10 EX-101.LAB ctrv-20160930_lab.xml EX-101.LAB 444788
11 EX-101.PRE ctrv-20160930_pre.xml EX-101.PRE 330752
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 161996345
SIC: 2834 Pharmaceutical Preparations